CN1864744A - 含有尿酸氧化酶的药用制剂 - Google Patents
含有尿酸氧化酶的药用制剂 Download PDFInfo
- Publication number
- CN1864744A CN1864744A CN 200510050354 CN200510050354A CN1864744A CN 1864744 A CN1864744 A CN 1864744A CN 200510050354 CN200510050354 CN 200510050354 CN 200510050354 A CN200510050354 A CN 200510050354A CN 1864744 A CN1864744 A CN 1864744A
- Authority
- CN
- China
- Prior art keywords
- urate oxidase
- pharmaceutical formulation
- clarification
- composition
- glycine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
样品 | 温度 | 0天 | 1天 | 2天 | ||||||
(℃) | 外观 | 酶活性 | PH | 外观 | 酶活性 | PH | 外观 | 酶活性 | PH | |
实施例1组合物 | -20 | 澄清 | 18.7 | 8.00 | 澄清 | 18.0 | 8.00 | 澄清 | 18.5 | 8.00 |
4 | 澄清 | 18.2 | 8.00 | 澄清 | 19.0 | 8.01 | 澄清 | 18.0 | 8.01 | |
25 | 澄清 | 18.9 | 8.00 | 澄清 | 18.8 | 8.00 | 澄清 | 17.8 | 8.00 | |
实施例2组合物 | -20 | 澄清 | 18.0 | 8.00 | 澄清 | 20.0 | 8.02 | 澄清 | 19.0 | 8.00 |
4 | 澄清 | 18.1 | 8.01 | 澄清 | 18.5 | 8.00 | 澄清 | 18.8 | 7.98 | |
25 | 澄清 | 18.6 | 8.00 | 澄清 | 17.9 | 8.00 | 澄清 | 18.1 | 8.00 | |
实施例3组合物 | -20 | 澄清 | 17.7 | 8.03 | 澄清 | 16 | 8.05 | 澄清 | 18.1 | 8.02 |
4 | 澄清 | 19.2 | 8.01 | 澄清 | 17 | 7.95 | 澄清 | 16.3 | 7.98 | |
25 | 澄清 | 15 | 8.00 | 澄清 | 16.5 | 8.04 | 澄清 | 17.1 | 7.97 | |
实施例4组合物 | -20 | 澄清 | 19.7 | 7.95 | 澄清 | 18.5 | 7.88 | 澄清 | 18.7 | 8.02 |
4 | 澄清 | 18.0 | 8.01 | 微浑 | 17.9 | 8.03 | 微浑 | 19.9 | 8.01 | |
25 | 澄清 | 17.2 | 7.99 | 微浑 | 18.0 | 8.10 | 微浑 | 18.1 | 7.87 | |
实施例5组合物 | -20 | 澄清 | 18.5 | 8.00 | 澄清 | 17.9 | 8.00 | 澄清 | 18.8 | 8.00 |
4 | 澄清 | 17.5 | 8.10 | 澄清 | 19.1 | 8.08 | 微浑 | 17.7 | 7.98 | |
25 | 微浑 | 16.9 | 8.02 | 微浑 | 15.9 | 8.07 | 有悬浮物 | 15.1 | 7.99 | |
实施例6组合物 | -20 | 澄清 | 18.3 | 8.10 | 澄清 | 16.7 | 8.00 | 澄清 | 17.7 | 8.00 |
4 | 澄清 | 17.2 | 7.95 | 澄清 | 18.1 | 7.87 | 澄清 | 18.4 | 7.77 | |
25 | 微浑 | 16.8 | 8.00 | 微浑 | 17.0 | 8.02 | 微浑 | 16.9 | 7.90 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100503548A CN1864744B (zh) | 2005-05-18 | 2005-05-18 | 含有尿酸氧化酶的药用制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100503548A CN1864744B (zh) | 2005-05-18 | 2005-05-18 | 含有尿酸氧化酶的药用制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1864744A true CN1864744A (zh) | 2006-11-22 |
CN1864744B CN1864744B (zh) | 2010-09-29 |
Family
ID=37423995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100503548A Active CN1864744B (zh) | 2005-05-18 | 2005-05-18 | 含有尿酸氧化酶的药用制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1864744B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816630B (zh) * | 2009-02-26 | 2012-07-04 | 重庆医科大学 | 尿酸酶脂质纳米粒及其制备方法 |
CN109223707A (zh) * | 2018-09-13 | 2019-01-18 | 中国药科大学 | 一种尿酸酶外用凝胶制剂、其制备方法及用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2733914B1 (fr) * | 1995-05-11 | 1997-08-01 | Sanofi Sa | Composition de liquide stable contenant de l'urate oxydase et composition lyophilisee pour sa preparation |
-
2005
- 2005-05-18 CN CN2005100503548A patent/CN1864744B/zh active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816630B (zh) * | 2009-02-26 | 2012-07-04 | 重庆医科大学 | 尿酸酶脂质纳米粒及其制备方法 |
CN109223707A (zh) * | 2018-09-13 | 2019-01-18 | 中国药科大学 | 一种尿酸酶外用凝胶制剂、其制备方法及用途 |
Also Published As
Publication number | Publication date |
---|---|
CN1864744B (zh) | 2010-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1258379C (zh) | 肉毒杆菌毒素药物组合物 | |
CN101095950B (zh) | 一种稳定的人用狂犬病疫苗冻干制剂及其制备 | |
Chen et al. | Studies of macrophage immuno-modulating activity of polysaccharides isolated from Paecilomyces tenuipes | |
CN111801106A (zh) | 赤红球菌产品在治疗温血动物的皮肤损伤或溃疡中的用途 | |
CN110358803B (zh) | 一种驴胎盘活性多肽的制备方法 | |
CN1814166A (zh) | 注射用生脉粉针制剂及其制备方法 | |
CN1864744A (zh) | 含有尿酸氧化酶的药用制剂 | |
CN1883707A (zh) | 重组腺病毒的冻干制剂及其制备方法 | |
Elisashvili et al. | Hypoglycemic, interferonogenous, and immunomodulatory activity of Tremellastin from the submerged culture of Tremella mesenterica Retz.: Fr.(Heterobasidiomycetes) | |
CN1313594C (zh) | 药食两用真菌细胞液的制备方法 | |
CN1314444C (zh) | 一种治疗糠尿病及其并发症和病毒性肝炎的组合药物及其制备方法 | |
CN104888196A (zh) | 一种稳定的干扰素α多剂量笔注射液 | |
CN1247259C (zh) | 重组人干扰素α喷雾剂 | |
CN1251681C (zh) | 静脉注射用高浓型水溶性维生素及其制备方法和用途 | |
CN100349614C (zh) | 一种含α-淀粉酶抑制剂的固体混合物及其制备工艺和在制药中的应用 | |
CN114317700B (zh) | 荧光pcr试剂冻干保护剂、冻干方法及应用 | |
CN1839822A (zh) | 一种含活性成分水飞蓟宾及其盐经注射给药的稳定的药物组合物 | |
CN1224390C (zh) | 含吡咯并喹啉醌的治疗和预防脂肪肝的药物组合物 | |
CN1802172A (zh) | 用于自身免疫性病症的治疗组合物 | |
CN1695737A (zh) | 冻干剂型艾滋病重组痘病毒安卡拉株载体疫苗及其制备方法 | |
CN1686378A (zh) | 一种复方鱼腥草注射制剂及制备方法和应用 | |
CN103191153B (zh) | 肌氨肽苷提取物及其药物组合物 | |
CN1660414A (zh) | 一种稳定的干扰素制剂 | |
CN1732912A (zh) | 一种不含辅料的硫普罗宁静脉注射用冻干制剂及制备工艺 | |
CN1830452A (zh) | 一种盐酸克林霉素冻干粉针剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JILIN XIUZHENG PHARMACEUTICAL NEW MEDICINE DEVELOP Free format text: FORMER OWNER: HANGZHOU BIODOOR BIOTECHNOLOGY CO., LTD. Effective date: 20101112 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310012 NO.28, WEN ER STREET, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 130012 NO.2426, QIANJIN AVENUE, NEW AND HIGH TECHNOLOGY ZONE, CHANGCHUN CITY, JILIN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101112 Address after: 130012 No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin Patentee after: Jilin xiuzheng pharmaceutical new medicine development Co., Ltd. Address before: 310012 No. two 28 street, Hangzhou, Zhejiang Patentee before: Hangzhou Biodoor Biotechnology Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: CHANGCHUN SHENGJINNUO BIOLOGICAL PHARMACEUTICAL CO Free format text: FORMER OWNER: JILIN XIUZHENG PHARMACEUTICAL NEW MEDICINE DEVELOPMENT CO., LTD. Effective date: 20150813 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150813 Address after: 130103 No. 1239 Shunda Road, hi tech Development Zone, Jilin, Changchun Patentee after: CHANGCHUN SHENGJINNUO BIOLOGICAL PHARMACEUTICAL CO., LTD. Address before: 130012 No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin Patentee before: Jilin xiuzheng pharmaceutical new medicine development Co., Ltd. |